{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T23:34:46Z","timestamp":1720308886467},"reference-count":48,"publisher":"EDP Sciences","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ANR","award":["ANR-14-EBOL-0002-01"],"award-info":[{"award-number":["ANR-14-EBOL-0002-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Ces derni\u00e8res ann\u00e9es, le virus Ebola a \u00e9t\u00e9 responsable d\u2019\u00e9pid\u00e9mies de grande ampleur. Les efforts de recherche ont permis la mise au point et l\u2019\u00e9valuation sur le terrain de plusieurs candidats vaccins. \u00c0 l\u2019heure actuelle, deux sont d\u00e9j\u00e0 homologu\u00e9s et utilis\u00e9s dans la lutte contre le virus en R\u00e9publique d\u00e9mocratique du Congo. Cette revue se propose de faire le point sur les diff\u00e9rents candidats vaccins, les essais cliniques qui ont \u00e9t\u00e9 men\u00e9s et les premiers r\u00e9sultats de terrain.<\/jats:p>","DOI":"10.1051\/medsci\/2020174","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:01:23Z","timestamp":1604581283000},"page":"1027-1033","source":"Crossref","is-referenced-by-count":0,"title":["Ebola, des premiers vaccins disponibles"],"prefix":"10.1051","volume":"36","author":[{"given":"Baptiste","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Volchkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Reynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMsr1904253","volume":"381","author":"Ilunga Kalenga","year":"2019","journal-title":"N Engl J Med"},{"key":"R2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat Microbiol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1051\/medsci\/20143006018","volume":"30","author":"Reynard","year":"2014","journal-title":"Med Sci (Paris)"},{"key":"R4","unstructured":"https:\/\/www.who.int\/publications\/i\/item\/ebola-virus-disease-democratic-republic-of-congo-external-situation-report-85-2019."},{"key":"R5","first-page":"1280","volume":"392","author":"Editorial","year":"2018","journal-title":"Lancet"},{"key":"R6","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.1817329116","volume":"116","author":"Wells","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008300","volume":"6","author":"Geisbert","year":"2004","journal-title":"Expert Rev Mol Med"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Reynard S, Journeaux A, Gloaguen E, et al. Immune parameters and outcomes during Ebola virus disease. JCI Insight 2019; 4.","DOI":"10.1172\/jci.insight.125106"},{"key":"R9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(18)30649-2","volume":"19","author":"Diallo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/14760584.2019.1698952","volume":"18","author":"Matz","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"R14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","volume":"392","author":"L\u00e9vy","year":"2018","journal-title":"Lancet"},{"key":"R15","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","volume":"85","author":"Geisbert","year":"2011","journal-title":"J Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"R17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/infdis\/jiz071","volume":"220","author":"Mutua","year":"2019","journal-title":"J Infect Dis"},{"key":"R18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/infdis\/jiz070","volume":"220","author":"Anywaine","year":"2019","journal-title":"J Infect Dis"},{"issue":"suppl 3","key":"R19","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","volume":"204","author":"Geisbert","year":"2011","journal-title":"J Infect Dis"},{"key":"R20","doi-asserted-by":"crossref","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog"},{"key":"R21","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"key":"R24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"R25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jix189","volume":"215","author":"Halperin","year":"2017","journal-title":"J Infect Dis"},{"key":"R26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/fmb-2019-0237","volume":"15","author":"Bache","year":"2020","journal-title":"Future Microbiol"},{"key":"R27","doi-asserted-by":"crossref","first-page":"317ps24","DOI":"10.1126\/scitranslmed.aad3106","volume":"7","author":"Medaglini","year":"2015","journal-title":"Sci Transl Med"},{"key":"R28","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1016\/j.vaccine.2018.09.009","volume":"37","author":"Juan-Giner","year":"2019","journal-title":"Vaccine"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Davis C, Tipton T, Sabir S, et al. Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report. Clin Infect Dis 2019; nov 30; ciz1165. doi: 10.1093\/cid\/ciz1165.","DOI":"10.1093\/cid\/ciz1165"},{"key":"R30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(19)30614-0","volume":"20","author":"Clarke","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vaccine.2010.10.024","volume":"29","author":"DiNapoli","year":"2010","journal-title":"Vaccine"},{"key":"R32","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","volume":"85","author":"Blaney","year":"2011","journal-title":"J Virol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2008.09.030","volume":"383","author":"Bukreyev","year":"2009","journal-title":"Virology"},{"key":"R34","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1172\/JCI81532","volume":"125","author":"Meyer","year":"2015","journal-title":"J Clin Invest"},{"key":"R35","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.00074-09","volume":"83","author":"Halfmann","year":"2009","journal-title":"J Virol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaa4919","volume":"348","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"R37","unstructured":"Dewitt T. Ebola vaccine inches toward human clinical trials. University of Wisconsin-Madison 2018. https:\/\/news.wisc.edu\/ebola-vaccine-inches-toward-human-clinical-trials\/."},{"key":"R38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(14)62385-0","volume":"385","author":"Kibuuka","year":"2015","journal-title":"Lancet"},{"key":"R39","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","volume":"34","author":"Bengtsson","year":"2016","journal-title":"Vaccine"},{"key":"R40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/infdis\/jiz518","volume":"222","author":"Fries","year":"2020","journal-title":"J Infect Dis"},{"key":"R41","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/infdis\/jiw218","volume":"214","author":"Marzi","year":"2016","journal-title":"J Infect Dis"},{"issue":"suppl 3","key":"R42","doi-asserted-by":"crossref","first-page":"S1082","DOI":"10.1093\/infdis\/jir350","volume":"204","author":"Falzarano","year":"2011","journal-title":"J Infect Dis"},{"key":"R43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/CVI.00107-16","volume":"23","author":"Natesan","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"R44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3201\/eid2603.191018","volume":"26","author":"Legardy-Williams","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"R46","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"R47","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","volume":"38","author":"Kasereka","year":"2020","journal-title":"Vaccine"},{"key":"R48","unstructured":"WHO prime boost ebola report https:\/\/www.who.int\/immunization\/research\/meetings_workshops\/WHO_primeboost_Ebola_21nov14_meeting_report.pdf."}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T19:59:26Z","timestamp":1604606366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"journal-issue":{"issue":"11"},"alternative-id":["msc200134"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2020174","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}